Symbol="BCLI"
AssetType="Common Stock"
Name="Brainstorm Cell Therapeutics Inc"
Description="Brainstorm Cell Therapeutics Inc., a biotechnology company, is dedicated to the development and commercialization of autologous cell therapies for the treatment of neurodegenerative diseases. The company is headquartered in New York, New York."
CIK="1137883"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="65629000"
EBITDA="-24220000"
PERatio="None"
PEGRatio="0"
BookValue="-0.126"
DividendPerShare="0"
DividendYield="0"
EPS="-0.63"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.91"
ReturnOnEquityTTM="-4.971"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.63"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="47.39"
EVToRevenue="-"
EVToEBITDA="-2.429"
Beta="-0.519"
num_52WeekHigh="4.7"
num_52WeekLow="1.085"
num_50DayMovingAverage="2.388"
num_200DayMovingAverage="2.306"
SharesOutstanding="43462600"
DividendDate="None"
ExDividendDate="None"
symbol="BCLI"
open="1.56"
high="1.75"
low="1.55"
price="1.72"
volume="502863.00"
latest_trading_day="2023-07-28"
previous_close="1.51"
change="0.21"
change_percent="13.9073%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="23"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="77"
Volume_recent_avg="337692"
Change_recent_avg="-0.01"
Delta_recent_avg="0.21"
Variance_recent_avg="0.11"
Change_ratio_recent_avg="-0.74"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="77"
Aroon_momentum_negative="23"
image_negative_thumbnail_id_1="1087"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0120.jpeg"
image_negative_thumbnail_id_2="1112"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0145.jpeg"
image_neutral_thumbnail_id_1="539"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="975"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0137.jpeg"
image_positive_thumbnail_id_2="698"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0010.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
